MedPath

Prolonged automatic oxygen support in preterm infants

Conditions
hypoxemia, hyperoxemia, hypoxie, hyperoxie
Registration Number
NL-OMON27305
Lead Sponsor
Academic Medical Center (AMC), Amsterdam
Brief Summary

one

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Preterm infants will be enrolled based on the following inclusion criteria:

• From day 7 of life after being born with a gestational age under 28 weeks

Exclusion Criteria

• Major congenital anomalies

• If the attending physician deems participation in the study is not in the best interest of the infant

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The hypotheses of this trial are based on the need to assess the effectiveness of A-FiO2 adjustments over time. The primary outcome variable is therefore defined as the proportion of time for both control settings with SpO2 within the assigned saturation TR (87-95%), measured over a time period of maximum 28 days and excluding time with SpO2 above the range while FiO2 is set at 0.21.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath